Isoptin

Verapamil Hydrochloride, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chest pain and certain heart rhythm disorders in adult patients. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin is a calcium channel blocker used in cardiovascular conditions that involve elevated vascular tone or abnormal cardiac conduction.

Hypertension: lowers blood pressure by relaxing arterial smooth muscle. Angina pectoris: reduces myocardial oxygen demand through vasodilation and decreased contractility. Atrial fibrillation: helps control ventricular rate by slowing atrioventricular conduction. Supraventricular tachycardia: terminates episodes by inhibiting rapid atrial impulses.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Dizziness or light‑headedness: related to blood pressure lowering. - Headache: often mild and transient. - Flushing: due to peripheral vasodilation.

Serious or Rare Side Effects: - Bradycardia or heart block: excessive slowing of cardiac conduction. - Severe hypotension: marked drop in blood pressure. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Allergic reactions: rash, angioedema, or anaphylaxis. - Cardiac failure exacerbation: worsening of pre‑existing heart failure.

Before initiating therapy, clinicians should evaluate cardiovascular status and potential risk factors.

Monitor blood pressure: adjust dose if hypotension occurs. Assess cardiac conduction: obtain ECG to detect pre‑existing AV block. Use caution in hepatic impairment: metabolism may be reduced. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Review concomitant beta‑blocker use: increased risk of bradycardia. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Verapamil can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Concurrent beta‑blockers: additive bradycardia and AV block. - Digoxin: increased serum digoxin levels, risk of toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): elevated verapamil concentrations.

Moderate Interactions (Monitor Closely): - Diltiazem: additive effects on cardiac conduction. - Amiodarone: may increase verapamil levels. - Macrolide antibiotics (e.g., erythromycin): moderate CYP3A4 inhibition. - Diuretics: enhanced hypotensive effect. - NSAIDs: may reduce antihypertensive response.